Patents, Patent Applications, Vaccinations

Lexicography: Clear And Unequivocal

Sheppard Mullin Richter & Hampton LLP on 7/22/2025

This Federal Circuit opinion analyzes lexicography in the context of claim construction. Alnylam Pharmaceuticals owns U.S. Patent Nos. 11,246,933 (parent) and 11,382,979 (child). These patents relate to biodegradable...more

Canadian Innovation During The COVID-19 Pandemic

International Lawyers Network on 12/2/2020

Canadian Innovation Week, namely November 16th to November 20th this year, is a movement organized by the Rideau Hall Foundation and Canadian Innovation Space which seeks to recognize Canadians advancing their respective...more

Enforcing IP in a Pandemic: Considerations, Risks, Strategies

Troutman Pepper Locke on 10/27/2020

Moderna, a biotechnology company that is currently advancing a leading COVID-19 vaccine candidate, recently stated that it would not enforce its vaccine patents during the current health crisis. In light of this...more

Patent Disputes in Life Sciences

International Lawyers Network on 9/24/2020

Having vast expertise in providing legal protection to large Russian and international pharmaceuticals and healthcare companies, Lidings has put together a Legal Digest highlighting the most notable patents disputes in Life...more

Accelerated examination of Canadian patent applications related to COVID-19 relief

Smart & Biggar on 7/14/2020

The Canadian Intellectual Property Office (CIPO) has launched a pilot program to provide accelerated examination of Canadian patent applications concerning medical technology related to COVID-19 and for which Health Canada...more

France – Rejection of a second SPC for a biological medicinal product

Hogan Lovells on 6/20/2018

Cour de cassation, Commercial Chamber, 16 May 2018, No. 16-21638 - The French Cour de cassation upholds the Paris Court of Appeal’s decision to reject an SPC application for a biological medicinal product which was based...more

Patents › Patent Applications › Vaccinations